Multiple modes of action of eribulin mesylate: Emerging data and clinical implication
https://www.cancertreatmentreviews.c...143-9/fulltext
Some key points in this article: Aside from its antimitotic activity, Eribulin (Halaven) enables better absorption of another drug after it, possible reverse endocrine resistance (so looking forward to this to be true), causes tumor to become less invasive and aggressive, suitable for metronomic method. Nguyen |
All times are GMT -7. The time now is 12:14 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021